US 8741315
Methods of treating tumors in immune-privileged sites
granted A61KA61K2039/5152A61K2239/31
Quick answer
US patent 8741315 (Methods of treating tumors in immune-privileged sites) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/5152, A61K2239/31, A61K2239/38, A61K2239/47